MDSO, CPA, ROSE, MITI, ONTY, LRN Expected To Be Up After Next Earnings Releases
November 7, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, November 8th 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. MEDIDATA SOLUTIONS INC (NASDAQ:MDSO), COPA HOLDINGS SA-CLASS A (NYSE:CPA), ROSETTA RESOURCES INC (NASDAQ:ROSE), MICROMET INC (NASDAQ:MITI), ONCOTHYREON INC (NASDAQ:ONTY), K12 INC (NYSE:LRN) are all expected to be Up After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Tuesday:
Symbol Company # of Reports Quarter Release Time MDSO MEDIDATA SOLUTIONS INC 6 Quarter Q3 Before CPA COPA HOLDINGS SA-CLASS A November Earnings Q3 After ROSE ROSETTA RESOURCES INC 6 Quarter Q3 Before MITI MICROMET INC November Earnings Q3 Before ONTY ONCOTHYREON INC 6 Quarter Q3 After LRN K12 INC 6 Quarter Q1 BeforeThis technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
MEDIDATA SOLUTIONS INC (NASDAQ:MDSO) - Medidata Solutions, Inc. provides hosted clinical development solutions for life science organizations worldwide. Its solutions include software and services that allow customers to achieve clinical results by streamlining the design, planning, and management of key aspects of the clinical development process, including protocol development, contract research organizations (CRO) negotiation, investigator contracting, the capture and management of clinical trial data, and the analysis and reporting of that data on a worldwide basis. The company primarily offers Medidata Rave, a comprehensive platform that integrates electronic data capture with a clinical data management system in a single solution. It also provides Medidata Designer application, a clinical trial protocol authoring tool that enables customers to write trial protocols and automatically configure Medidata Rave. In addition, the company offers Medidata Grants Manager, which enables its customers to benchmark their investigator budgets against industry data, as well as their own grant history; and Medidata CRO Contractor that focuses on benchmarks for CRO outsourcing, budgeting, and negotiation. Further, it provides professional services, including implementation services to meet customers data requirements for various indications; workflow design to meet the needs of various study phases and global regulatory requirements; and guidance on best practices for using its application services. The companys customers include pharmaceutical, biotechnology, and medical device companies; academic institutions; clinical research organizations; and other entities engaged in clinical trials. It markets and sells its application services through a direct sales force, and through relationships with CROs and other strategic partners. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.
COPA HOLDINGS SA-CLASS A (NYSE:CPA) - Copa Holdings, S. A., through its subsidiaries, provides airline passenger and cargo services. The company offers air transportation services for leisure and business travelers; and cargo, which include freight, courier, and mail service. It provides 156 daily scheduled flights for 45 destinations in 24 countries in North, Central, and South America; and the Caribbean. As of December 31, 2009, the company operated a fleet of 42 aircraft consisting of 29 modern Boeing 737-Next Generation aircraft; and 13 Embraer 190 aircraft. It has a strategic alliance with Continental Airlines, Inc. Copa Holdings, S.A. was founded in 1947 and is based in Panama City, Panama.
ROSETTA RESOURCES INC (NASDAQ:ROSE) - Rosetta Resources Inc., an independent oil and gas company, together with its subsidiaries, engages in the acquisition, exploration, development, and production of oil and gas properties in the United States. Its operations are primarily located in the Sacramento Basin of California, the Rockies, the Lobo, and Perdido Trends in South Texas; the State Waters of Texas; and the Gulf of Mexico. As of December 31, 2009, the company had an estimated 351.1 Bcfe of proved oil and natural gas reserves, including 296.8 Bcf of natural gas, 3,825 MBbls of oil and condensate, and 5,221 MBbls of natural gas liquids, as well as participated in the drilling of 43 gross wells. Rosetta Resources Inc. is headquartered in Houston, Texas.
MICROMET INC (NASDAQ:MITI) - Micromet Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibodies for the treatment of cancer, inflammation, and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE antibody platform, as well as conventional monoclonal antibodies. The companys lead product MT103 is in Phase II clinical trial for the treatment of acute lymphoblastic leukemia, as well as in Phase I trial for non-Hodgkins lymphoma. Its Phase II trial product also includes MT201 for solid tumors; and Phase I trial products comprise MT110 and MT293 for solid tumors, and MT203 for the treatment of inflammatory diseases. The companys products in preclinical stage include MT111 to treat solid tumors; BiTE antibody for acute myelogenic lymphoma and solid tumors; MT228 for melanoma; and MT204 for the treatment of inflammatory diseases, including rheumatoid arthritis, asthma, acute transplant rejection, uveitis, psoriasis, and multiple sclerosis. It has license agreements and collaborations with Biovation Limited; Enzon Pharmaceuticals, Inc.; MedImmune LLC; Bayer Schering Pharma AG; TRACON Pharmaceuticals, Inc.; Nycomed A/S; Morphotek, Inc.; Sanofi-Aventis; and Boehringer Ingelheim. The company is headquartered in Bethesda, Maryland.
ONCOTHYREON INC (NASDAQ:ONTY) - Oncothyreon Inc., a clinical-stage biopharmaceutical company, focuses primarily on the development of therapeutic products for the treatment of cancer. Its product under development includes ONT-10, a synthetic MUC1-based liposomal glycolipopeptide cancer vaccine for use in various cancer indications, including breast, thyroid, colon, stomach, pancreas, and prostate, as well as in certain types of lung cancer. The company is also developing small molecule drugs, such as PX-866, a Phase I trial product for the patients with advanced metastatic cancer; and PX-478 that completed enrollment in a Phase I trial for the patients with advanced metastatic cancer. It operates in Canada, the United States, Barbados, and Europe. The company was founded in 1985 and is headquartered in Seattle, Washington.
K12 INC (NYSE:LRN) - K12 Inc., a technology-based education company, provides proprietary curriculum and educational services for online delivery to students in kindergarten through 12th grade (K12) primarily in the United States. Its products include K12 Curriculum, which consists of online lessons, offline learning kits, and lessons guides; Online School (OLS) platform, a Web-based software platform that provides access to its online lessons, as well as its lesson planning and scheduling tools and progress tracking tool; Student Administration Management System, a proprietary student information system, which integrates with the OLS and several other proprietary systems, including its online enrollment system, which allows parents to complete school enrollment forms online; and TotalView, a suite of online applications that provides administrators, teachers, parents, and students a unified view of student progress, attendance, communications, and learning kit shipment tracking. The company also offers a combination of tools that foster communication and interaction among virtual public school students and parents. In addition, it provides a range of academic support services, including teachers and related services, gifted and special education services, and student support services; and management services, such as compliance and tracking services, financial support services, and human resources support services, as well as facility, operations, and technology support services. The company distributes its products and services primarily to virtual public schools, school districts, private schools, charter schools, and directly to consumers. K12 Inc. was founded in 2000 and is headquartered in Herndon, Virginia.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641